Systemic Immune-inflammation Index in Evaluation of Inflammation in Rheumatoid Arthritis Patients
Open Access
- 5 September 2024
- journal article
- research article
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 39 (3) , 183-191
Abstract
To evaluate the systemic immune-inflammation (SII) index in patients with rheumatoid arthritis (RA) stratified by systemic inflammatory status. Seropositive patients with RA (n=58) were divided into two groups based on serum hs-C-reactive protein (hs-CRP) levels: RA patients with hs-CRP levels of at or 3 mg/L or above (high systemic inflammatory status; n=38) and RA patients with hs-CRP levels of less than 3 mg/L (low systemic inflammatory status; n=20). The control group comprised 31 healthy individuals. Blood samples were tested for the next parameters: leukocytes, neutrophilic granulocytes, lymphocytes, thrombocytes [platelet (PLT)], high-sensitivity hs-CRP, sed rate [erythrocyte sedimentation rate (ESR)], neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR). The SII index was derived as Neu x PLT/Lym. In patients with RA, the SII index was elevated compared with that of healthy individuals and positively correlated with hs-CRP, erythrocyte sedimentation rate, NLR, MLR, PLR, tender joint count, and swollen-to-tender joint count ratio. Patients with RA who had hs-CRP levels of 3 mg/L above exhibited a statistically significant increase in the SII compared with those with hs-CRP levels below 3 mg/L. Additionally, within the cohort of RA patients with hs-CRP levels at or above 3 mg/L, a positive correlation was found between the SII index and both NLR and PLR. The SII index was positively correlated with NLR, MLR, and PLR in RA patients with hs-CRP levels below 3 mg/L. The cut-off point of the SII index for distinguishing between RA cases with hs-CRP levels 3 mg/L and those with hs-CRP levels 3 mg/L or higher was ≥323.4, with a sensitivity of 77.6% and a specificity of 54.8%. The serum SII index can be a potentially useful marker for evaluating the inflammatory process and clinical progression of RA.Keywords
This publication has 25 references indexed in Scilit:
- Elevated systemic immune inflammation index level is associated with disease activity in ulcerative colitis patientsClinica Chimica Acta, 2021
- Innate immunity drives pathogenesis of rheumatoid arthritisBiomedical Journal, 2021
- C-reactive protein and implications in rheumatoid arthritis and associated comorbiditiesSeminars in Arthritis and Rheumatism, 2021
- The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin LevelsAnnals of Surgery, 2019
- Rheumatoid arthritisThe Lancet, 2016
- The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulationAtherosclerosis, 2015
- Lymphocyte Trafficking to Mucosal Tissues2015
- Inflammatory markers in patients with rheumatoid arthritisAllergologia et Immunopathologia, 2015
- Discrepancies in categorizing rheumatoid arthritis patients by DAS-28(ESR) and DAS-28(CRP): can they be reduced?Rheumatology, 2010
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988